Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Milk is provided to new borns as their first food source and it contains essential nutrients, vitamins and other beneficial components, such as enzymes and antibodies that are required for rapid growth and development of the new born and for sustained growth over time. Milk contains two main types of proteins; casein proteins and whey proteins. Although casein proteins account for up to 80% of the proteins found in bovine milk, it is the whey protein that has become of high interest because of its bioactive content. Whey, a very watery mixture of lactose, proteins, minerals and trace amounts of fat, is formed from milk when the milk is coagulated and/or the casein proteins are removed from the milk. Bovine whey protein, including both the acidic and basic fractions (low and high isoelectric point, respectively), has previously been studied in vitro (cell based) and in vivo (using rats) for its impact on bone to determine if it can help improve bone mineral density and help reduce the risk of developing bone diseases, such as osteoporosis. Bone is constantly undergoing a remodelling process of being dissolved and reformed and the two main cell types responsible for this bone remodelling process are mature osteoclasts, which dissolve (resorb) bone, and osteoblasts, which reform the bone. Prior work has shown that acidic protein fractions derived from different sources of whey protein concentrate (WPC) have both in vivo and in vitro activity on bone, particularly anti-resorptive properties. However, the component(s) which confer activity have not yet been identified. In this thesis, work was undertaken to better understand the analytical composition of three types of WPC (cheese, mineral acid and lactic acid) and their associated acidic protein fractions and relate this to bone activity in the hope of identifying where the activity lies. Bone activity was assessed using in vitro screening with osteoblast cells (MC3T3-E1) and osteoclast cells (RAW 264.7). Comparison of the cell-based bone activity of the parent WPCs and corresponding acidic fractions indicated that the acidic fractions derived from both mineral acid and lactic WPC were superior in their ability to inhibit osteoclast development. Although compositional data was complex and definitive correlations with both bone bioactivities could not be made, it appeared that elements common to both the acidic fractions were a higher proportion of GLYCAM-1 and bone sialoprotein-1 (osteopontin). Further studies to more closely investigate the bone bioactivity of the acidic fractions are warranted.

Orientador: Ana Lúcia Barretto Penna / Banca: Elisa Helena Giglio Ponsano / Banca: Célia Maria Landi Franco / Resumo: O queijo Prato é caracterizado como gordo e de média umidade, sendo o segundo mais consumido no país. Contudo, a associação da ingestão de gorduras com o desenvolvimento de doenças coronarianas e carcinogênicas tem incentivado a procura por alimentos menos calóricos e que, ao mesmo tempo, sejam tão agradáveis ao paladar quanto às versões integrais. Algumas melhorias tecnológicas foram desenvolvidas para promover bons aspectos físicos e sensoriais para queijos com baixo teor de gordura, incluindo o uso de substitutos de gordura. Nesta pesquisa, foram incorporados ao queijo Prato dois diferentes substitutos de gordura, aplicados simultaneamente, a fim de avaliar o efeito sobre a qualidade tecnológica desse queijo. Foram feitos dois processamentos dos queijos conforme 3 tratamentos: um controle, fabricado com leite integral e dois fabricados com leite padronizado a 1,5% de gordura: um queijo Prato light e outro queijo Prato light modificado, adicionado dos substitutos de gordura concentrado protéico de soro (CPS) e colágeno hidrolisado, nas concentrações de 1,0 e 0,5%, respectivamente. Durante o processo de maturação foram realizadas análises físico-químicas para a caracterização dos produtos, avaliação da proteólise, do derretimento e da textura. Os resultados obtidos para o conteúdo de gordura permitiram que os queijos fossem classificados como produtos light, por apresentarem redução maior que 25%, em relação ao conteúdo médio de gordura do queijo Prato integral. A adição dos substitutos promoveu aumento do teor de umidade e, conseqüentemente, do rendimento dos queijos. O comportamento da glicólise e da proteólise durante a maturação do queijo Prato light modificado foi próximo ao observado para o queijo Prato integral. Entretanto, não houve uma relação entre a adição dos substitutos de gordura e aumento da capacidade de derretimento... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Prato cheese is characterized as fatty and with medium moisture, it is very appreciated by consumers, being the second most consumed in the country. However, the association of fat intake with the development of coronary heart disease and cancers has prompted the search for food with fewer calories, but, at the same time, it must be as pleasing to taste as the full fat counterparts. Some alternatives were developed to improve physical and sensory characteristics in cheeses with reduced fat, including the use of fat substitutes. In this research, two different types of substitutes were incorporated into Prato cheese, to evaluate the effect on the technological quality of this cheese. The cheeses were prepared according to three treatments: a control, made with full fat milk and two made from standardized milk, a Prato light cheese and another Prato light cheese with added fat replacers: whey protein concentrate (WPC) and hydrolyzed collagen, respectively at a concentration of 1.0 and 0.5%, and repeated twice. During the ripening, the cheeses were submitted to analyses of the evaluation of proteolysis, melting and texture. The results obtained for the fat content allow the cheeses to be classified as light products, because they presented more than 25% of reduction, compared with the average fat content of a full fat Prato cheese. The addition of substitutes promoted an increase in moisture content and, consequently, in the yield of cheese; there was no influence on the acidity and proteolysis development. On the other hand, there was no relationship between the addition of fat substitutes and increasing the melting capacity and improving the texture of the Prato light cheese. Thus, further studies are needed to better understand the effect of whey protein concentrate and hydrolyzed collagen in the quality of these products, in order to assess their potential for production... (Complete abstract click electronic access below) / Mestre

Made available in DSpace on 2014-06-11T19:29:48Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-04-26Bitstream added on 2014-06-13T20:20:07Z : No. of bitstreams: 1 diamantino_im_me_sjrp.pdf: 386013 bytes, checksum: b3b87690b057fd61f3bc7ef1ddfed013 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / O queijo Prato é caracterizado como gordo e de média umidade, sendo o segundo mais consumido no país. Contudo, a associação da ingestão de gorduras com o desenvolvimento de doenças coronarianas e carcinogênicas tem incentivado a procura por alimentos menos calóricos e que, ao mesmo tempo, sejam tão agradáveis ao paladar quanto às versões integrais. Algumas melhorias tecnológicas foram desenvolvidas para promover bons aspectos físicos e sensoriais para queijos com baixo teor de gordura, incluindo o uso de substitutos de gordura. Nesta pesquisa, foram incorporados ao queijo Prato dois diferentes substitutos de gordura, aplicados simultaneamente, a fim de avaliar o efeito sobre a qualidade tecnológica desse queijo. Foram feitos dois processamentos dos queijos conforme 3 tratamentos: um controle, fabricado com leite integral e dois fabricados com leite padronizado a 1,5% de gordura: um queijo Prato light e outro queijo Prato light modificado, adicionado dos substitutos de gordura concentrado protéico de soro (CPS) e colágeno hidrolisado, nas concentrações de 1,0 e 0,5%, respectivamente. Durante o processo de maturação foram realizadas análises físico-químicas para a caracterização dos produtos, avaliação da proteólise, do derretimento e da textura. Os resultados obtidos para o conteúdo de gordura permitiram que os queijos fossem classificados como produtos light, por apresentarem redução maior que 25%, em relação ao conteúdo médio de gordura do queijo Prato integral. A adição dos substitutos promoveu aumento do teor de umidade e, conseqüentemente, do rendimento dos queijos. O comportamento da glicólise e da proteólise durante a maturação do queijo Prato light modificado foi próximo ao observado para o queijo Prato integral. Entretanto, não houve uma relação entre a adição dos substitutos de gordura e aumento da capacidade de derretimento... / Prato cheese is characterized as fatty and with medium moisture, it is very appreciated by consumers, being the second most consumed in the country. However, the association of fat intake with the development of coronary heart disease and cancers has prompted the search for food with fewer calories, but, at the same time, it must be as pleasing to taste as the full fat counterparts. Some alternatives were developed to improve physical and sensory characteristics in cheeses with reduced fat, including the use of fat substitutes. In this research, two different types of substitutes were incorporated into Prato cheese, to evaluate the effect on the technological quality of this cheese. The cheeses were prepared according to three treatments: a control, made with full fat milk and two made from standardized milk, a Prato light cheese and another Prato light cheese with added fat replacers: whey protein concentrate (WPC) and hydrolyzed collagen, respectively at a concentration of 1.0 and 0.5%, and repeated twice. During the ripening, the cheeses were submitted to analyses of the evaluation of proteolysis, melting and texture. The results obtained for the fat content allow the cheeses to be classified as light products, because they presented more than 25% of reduction, compared with the average fat content of a full fat Prato cheese. The addition of substitutes promoted an increase in moisture content and, consequently, in the yield of cheese; there was no influence on the acidity and proteolysis development. On the other hand, there was no relationship between the addition of fat substitutes and increasing the melting capacity and improving the texture of the Prato light cheese. Thus, further studies are needed to better understand the effect of whey protein concentrate and hydrolyzed collagen in the quality of these products, in order to assess their potential for production... (Complete abstract click electronic access below)

No description available.